A Phase 2 interventional study of Dexpanthenol foam spray, new formulation and Dexpanthenol foam spray, old formulation in Skin Abnormalities, sponsored by Bayer. Completed at 1 site in France. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-10-15.
Sponsored by Bayer · Phase 2, Interventional, and Treatment
The study focuses to prove the equivalent moisturizing effect of two different Dexpanthenol formulations
Exclusion Criteria:
Drug: Dexpanthenol foam spray, new formulation
Drug: Dexpanthenol foam spray, old formulation
2 applications of 2 micro liter/square centimeter on a 4X4 cm area corresponding to 32 micro liter
2 applications of 2 micro liter/square centimeter on a 4X4 cm area corresponding to 32 micro liter
Area Under Curve (AUC) of the cutaneous hydration rate measured with corneometer between T0 and T5h
Time frame: 0 min, 15 min, 30 min, 1h, 2h, 3h, 5h
Cutaneous hydration rate
Time frame: 15 min, 30 min, 1h, 2h, 3h, 5h
Incidence of Adverse Events
Time frame: FPFV - LPLV
This study is completed, as verified in Oct 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bayer